Phase4 Partners Ltd - Net Worth and Insider Trading
Phase4 Partners Ltd Net Worth
The estimated net worth of Phase4 Partners Ltd is at least $47 Million dollars as of 2025-04-25. Phase4 Partners Ltd is the 10% Owner of Albireo Pharma Inc and owns about 1,065,447 shares of Albireo Pharma Inc (ALBO) stock worth over $47 Million. Details can be seen in Phase4 Partners Ltd's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Phase4 Partners Ltd has not made any transactions after 2018-01-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Phase4 Partners Ltd
Phase4 Partners Ltd Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Phase4 Partners Ltd owns 1 companies in total, including Albireo Pharma Inc (ALBO) .
Click here to see the complete history of Phase4 Partners Ltd’s form 4 insider trades.
Insider Ownership Summary of Phase4 Partners Ltd
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ALBO | Albireo Pharma Inc | 2018-01-30 | 10 percent owner |
Phase4 Partners Ltd Latest Holdings Summary
Phase4 Partners Ltd currently owns a total of 1 stock. Phase4 Partners Ltd owns 1,065,447 shares of Albireo Pharma Inc (ALBO) as of January 30, 2018, with a value of $47 Million.
Latest Holdings of Phase4 Partners Ltd
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALBO | Albireo Pharma Inc | 2018-01-30 | 1,065,447 | 44.15 | 47,039,485 |
Holding Weightings of Phase4 Partners Ltd
Phase4 Partners Ltd Form 4 Trading Tracker
According to the SEC Form 4 filings, Phase4 Partners Ltd has made a total of 0 transactions in Albireo Pharma Inc (ALBO) over the past 5 years. The most-recent trade in Albireo Pharma Inc is the sale of 100,000 shares on January 30, 2018, which brought Phase4 Partners Ltd around $3 Million.
Insider Trading History of Phase4 Partners Ltd
- 1
Phase4 Partners Ltd Trading Performance
Phase4 Partners Ltd Ownership Network
Ownership Network List of Phase4 Partners Ltd
Ownership Network Relation of Phase4 Partners Ltd
Phase4 Partners Ltd Owned Company Details
What does Albireo Pharma Inc do?
Who are the key executives at Albireo Pharma Inc?
Phase4 Partners Ltd is the 10 percent owner of Albireo Pharma Inc. Other key executives at Albireo Pharma Inc include director & President and CEO Cooper Ronald Harold Wilfred , Chief Human Resources Officer Michelle Graham , and CFO and Treasurer Harford Simon N.r. .
Albireo Pharma Inc (ALBO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Albireo Pharma Inc (ALBO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Albireo Pharma Inc (ALBO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Albireo Pharma Inc (ALBO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Albireo Pharma Inc Insider Transactions
Phase4 Partners Ltd Mailing Address
Above is the net worth, insider trading, and ownership report for Phase4 Partners Ltd. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Phase4 Partners Ltd's mailing address is: London X0 W1j 8lq.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
